Used EXOMIND for Sale (2026)

Why there's almost no used EXOMIND yet

EXOMIND reached the US market in 2024, which is too recent for a meaningful secondary market to form. Practices that bought the device are still ramping it, not reselling it, so clean used inventory is scarce and there is no settled resale benchmark. The new price is $100,000-$200,000, and any used listing you do find should be treated with caution: at this stage, a discounted unit is more likely a distressed sale or a private resale with no support path than a vetted refurbished console.

Practically, most buyers searching for a "used EXOMIND" are trying to lower the capital cost. The better lever right now is negotiating the new deal. Reps have real pricing flexibility, especially at quarter-end and for practices that already run BTL aesthetic devices, and a new unit keeps the warranty, current software, and training that a private used purchase would forfeit. Revisit the used market in a year or two once the installed base matures.

When a used EXOMIND does eventually trade, the Section 179 tax deduction will apply as long as the unit is new to the buyer, the same first-year benefit a new purchase earns. That helps the after-tax math on refurbished equipment, but it does not offset the support and software risks covered below.

Where a used EXOMIND would surface

If a used EXOMIND comes to market in the next year or two, these are the channels to watch. Expect listings to be rare and to require extra due diligence given how new the platform is:

• BTL directly. Since BTL distributes EXOMIND through its own network, the cleanest path to a supported pre-owned or trade-in unit is BTL itself. A factory-handled unit is the only one likely to come with confirmed software access and any transferable support.
• Practices closing or pivoting. Early-adopter clinics that bought in and could not fill the schedule are the most likely first sellers. The savings can be real, but there is no dealer warranty and you carry the support risk.
• DOTmed (dotmed.com). The largest medical equipment marketplace and the logical place a private EXOMIND listing would eventually appear. Verify the seller's rating and confirm the unit with BTL before sending money.
• General used-equipment brokers. Brokers occasionally source niche TMS consoles, but for a 2024-cleared device, treat any "in stock" claim skeptically and confirm the specific serial number and software status.

Used EXOMIND verification checklist

Before committing to a used EXOMIND purchase, verify every item below. A pre-purchase inspection by an independent biomedical technician (cost: $300-$800) is almost always worth the expense and can save you from buying a non-functional or compromised unit.

• Software version. Confirm the unit is running current software, not a deprecated version that can't be updated.
• Software lock-out status. Get written confirmation from BTL Industries that the software will remain unlocked after ownership transfer. Some manufacturers require re-registration fees of $5,000-$25,000.
• ExoTMS coil condition. Inspect the treatment coil and positioning hardware for wear or damage. A replacement coil is a meaningful cost and may have a lead time.
• Pulse count and operating hours. TMS coils and consoles have a finite duty cycle. A high-pulse unit may need imminent service, so pull the diagnostic report.
• Original purchase date and ownership history. Verify how many owners the unit has had.
• Current warranty status. Some warranties are transferable; most are not. Understand what protection you're getting.
• FDA registration. Confirm the unit is properly registered for the specific clinical indications you plan to use it for.
• Included consumables. Get an itemized list of any consumables included with the purchase.
• Training documentation. Original training certificates may not transfer; budget for new training if needed.
• Return policy. Understand the dealer's return window, shipping responsibility, and inspection fees.

Risks of buying used EXOMIND

The biggest risks in buying used medical devices are not always the obvious ones. Mechanical condition matters less than these issues:

Software lock-out. The single biggest financial risk in used medical device purchases. Some manufacturers disable software when devices change ownership, requiring buyers to pay re-registration fees of $5,000-$25,000 to restore functionality. Always verify software status with the manufacturer in writing before purchase.

Outdated software with no upgrade path. Some manufacturers refuse software updates on second-hand units. You may end up with a working device that can't access current treatment protocols or software features. Verify the upgrade policy before committing.

Hidden hour or pulse counts. Devices with high operating hours may need imminent expensive service. Always run diagnostic reports during pre-purchase inspection to verify usage history.

Worn or damaged coil. A replacement ExoTMS coil is a meaningful expense and may carry a lead time, so inspect it and confirm a replacement is available before you commit.

Manufacturer support changes. If BTL Industries discontinues the platform or sells the product line, parts and service may become difficult or expensive. Check the manufacturer's strategic direction before buying older platforms.

Trade-in valuation games. If you're trading in equipment to BTL Industries as part of a new purchase, the trade-in offer is often 20-40% below true secondary market value. Selling directly to a used equipment dealer usually nets more cash.

Used vs new EXOMIND: the realistic call

Because there is no settled used EXOMIND price, you cannot bank on a specific secondary-market discount the way you can for an established TMS console. Any savings on a used unit have to be weighed against losing the warranty, current software, training, and confirmed support that come with a new purchase, which matter more on a device this early in its lifecycle.

For almost every buyer in 2026, the better move is a negotiated new unit rather than a used one. The exception is a practice that finds a BTL-handled trade-in with confirmed software access and some support, which removes the two biggest used-equipment risks. A bare private-sale console with no support path is rarely worth the discount on a 2024-cleared device.

The right candidate for used equipment here is an experienced buyer who has already validated patient demand, can verify the unit's condition and software status, and has gotten the support terms from BTL in writing. First-time buyers should pay the premium for new to get warranty, training, and manufacturer support during the ramp.